Atalanta Therapeutics

Website

Developer of targeted RNA-modulating therapeutics designed for the treatment of genetically defined diseases. The company utilizes proprietary structure-switching molecules to modulate gene expression...

Healthcare
Boston, MA, United States
Founded 2018
55 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$227M
Last Round
N/A
Investors
+11 other investors
View all 11 investors
Valuation History
0 funding rounds on record
Cap Table
Ownership structure
Market Activity
Secondary transactions

Get the full picture

Create a free account to unlock Atalanta Therapeutics's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required